Thymic Humoral Factor
Thymic humoral factor possesses immunomodulator properties and was undergoing phase I studies in HIV-positive patients (Anon, 1989). Adria Laboratories (Dublin, OH), the manufacturer of thymic humoral factor, is discontinuing further research and distribution of this agent effective at the end of 1995. Increases number of T-lymphocytes and augments cell-mediated immunity.
This drug should NOT be coded